Chemoinformaics analysis of (1R,6S)-7,7-DIMETHYL-3-METHYLIDENEBICYCLO[4.1.0]HEPTANE
| Molecular Weight | 136.238 | nRot | 0 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 25 |
| Exact Molecular Weight | 136.125 | nRing | 2 |
| Solubility: LogS | -6.266 | nHRing | 0 |
| Solubility: LogP | 3.266 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.3687 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.54 |
| Synth | 2.64 |
| Natural Product Likeliness | 1.187 |
| NR-PPAR-gamma | 0.144 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.093 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.915 |
| MDCK | 0.0000204 |
| BBB | 0.317 |
| PPB | 0.959972 |
| VDSS | 0.662 |
| FU | 0.0176103 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.523 |
| CYP2c19-inh | 0.905 |
| CYP2c19-sub | 0.197 |
| CYP2c9-inh | 0.699 |
| CYP2c9-sub | 0.913 |
| CYP2d6-inh | 0.607 |
| CYP2d6-sub | 0.897 |
| CYP3a4-inh | 0.833 |
| CYP3a4-sub | 0.162 |
| CL | 12.78 |
| T12 | 0.165 |
| hERG | 0.056 |
| Ames | 0.917 |
| ROA | 0.069 |
| SkinSen | 0.109 |
| Carcinogencity | 0.959 |
| EI | 0.616 |
| Respiratory | 0.833 |
| NR-Aromatase | 0.675 |
| Antiviral | No |
| Prediction | 0.9127 |